Skip to content
Home/Companies/Biotech/Auron Therapeutics
AT

Auron Therapeutics

Biotech·United States·Active·4yr hold

Auron Therapeutics is a biotech company, headquartered in United States.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Auron Therapeutics?

Auron Therapeutics is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund II (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Investor
Apollo Health Ventures
Apollo Health Ventures Fund II · 2021 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Apollo Health Ventures Fund II

Other portfolio companies in the same fund.

Therini Bio
Active
BiotechUnited States· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Cleara Biotech
Active
BiotechNetherlands· 2022
Focal Biosciences
Active
BiotechSwitzerland· 2022
Bloom Science
Active
BiotechUnited States· 2021
HAYA Therapeutics
Active
BiotechSwitzerland· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings